News
Sarepta Therapeutics is pausing shipments of its gene therapy for muscular dystrophy following several patient deaths that ...
The FDA's assessment of the bread recall has designated it as a Class II risk, which means the product "may cause temporary ...
A Food and Drug Administration expert panel has reignited a debate over whether hormone therapy should be used to treat ...
Prefilled syringe eliminates the need to reconstitute separate vials prior to administration and simplifies the vaccine ...
This latest approval builds on an earlier liquid formulation of generic methimazole for feline hyperthyroidism, which ...
Taking medication for an allergic reaction? You might face severely itchy skin as a side effect of Zyrtec or Xyzal, according ...
Explore more
Dr. George Tidmarsh, a Stanford pediatrics adjunct professor and former pharmaceutical executive, is FDA Commissioner Marty Makary’s pick to be the nation’s top drug regulator.
(The Center Square) – Doctors on Monday urged the U.S. Food and Drug Administration to issue warnings to pregnant women ...
Lexi Homberger — a third grade teacher at Dodge Elementary — was recognized in 2023, by the Williamsville School Board, after ...
2hon MSN
After the FDA request, Cambridge, Massachusetts-based Sarepta said in a statement that it will continue to ship the therapy ...
The Food and Drug Administration has identified a Class I recall of certain lots of Medline Industries Craniotomy ...
This is the web edition of D.C. Diagnosis, STAT's twice-weekly newsletter about the politics and policy of health and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results